An ANOCEF Genomic and Transcriptomic Microarray Study of the Response to Irinotecan and Bevacizumab in Recurrent Glioblastomas
出版年份 2014 全文链接
标题
An ANOCEF Genomic and Transcriptomic Microarray Study of the Response to Irinotecan and Bevacizumab in Recurrent Glioblastomas
作者
关键词
-
出版物
Biomed Research International
Volume 2014, Issue -, Pages 1-8
出版商
Hindawi Limited
发表日期
2014-04-03
DOI
10.1155/2014/282815
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pretreatment ADC Histogram Analysis Is a Predictive Imaging Biomarker for Bevacizumab Treatment but Not Chemotherapy in Recurrent Glioblastoma
- (2013) B. M. Ellingson et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma
- (2013) Emeline Tabouret et al. NEURO-ONCOLOGY
- Hypertension as a biomarker in patients with recurrent glioblastoma treated with antiangiogenic drugs
- (2012) Giuseppe Lombardi et al. ANTI-CANCER DRUGS
- Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951
- (2012) Lale Erdem-Eraslan et al. JOURNAL OF CLINICAL ONCOLOGY
- Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45
- (2011) Hua Li et al. CANCER
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Platelet-derived Growth Factor-DD Targeting Arrests Pathological Angiogenesis by Modulating Glycogen Synthase Kinase-3β Phosphorylation
- (2010) Anil Kumar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients
- (2010) François Ducray et al. Molecular Cancer
- Micron-Scale Spatially Patterned, Covalently Immobilized Vascular Endothelial Growth Factor on Hydrogels Accelerates Endothelial Tubulogenesis and Increases Cellular Angiogenic Responses
- (2010) Julia E. Leslie-Barbick et al. TISSUE ENGINEERING PART A
- Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology
- (2009) L. A.M. Gravendeel et al. CANCER RESEARCH
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays
- (2009) Tatiana Popova et al. GENOME BIOLOGY
- Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios
- (2008) Johan Staaf et al. BMC BIOINFORMATICS
- Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan
- (2008) Sith Sathornsumetee et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now